NCT06782971View on ClinicalTrials.gov

Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX

RecruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

June 6, 2025

Primary Completion Date

February 29, 2028

Study Completion Date

March 31, 2030

Conditions
AML - Acute Myeloid Leukemia
Trial Locations (4)

2031

RECRUITING

Prince of Wales Hospital, Sydney

2065

NOT_YET_RECRUITING

Royal North Shore Hospital, Sydney

2145

NOT_YET_RECRUITING

Westmead Hospital, Westmead

2605

NOT_YET_RECRUITING

Canberra Health Services, Canberra

Sponsors

Collaborators (1)

Cancer Institute NSW
All Listed Sponsors
collaborator

Cancer Institute NSW

UNKNOWN

collaborator

The University of New South Wales

OTHER

collaborator

Australian National University

OTHER

lead

Clinical Hub for Interventional Research (CHOIR)

OTHER_GOV